List of Tables
Table 1. Global Injectable Thyroid Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Injectable Thyroid Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Injectable Thyroid Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Injectable Thyroid Drug Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Injectable Thyroid Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Injectable Thyroid Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Injectable Thyroid Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Injectable Thyroid Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Injectable Thyroid Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Injectable Thyroid Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Injectable Thyroid Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Injectable Thyroid Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable Thyroid Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injectable Thyroid Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Thyroid Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Injectable Thyroid Drug Sales by Region (K Units), 2021–2026
Table 18. Global Injectable Thyroid Drug Sales Market Share by Region (2021–2026)
Table 19. Global Injectable Thyroid Drug Sales by Region (K Units), 2027–2032
Table 20. Global Injectable Thyroid Drug Sales Market Share by Region (2027–2032)
Table 21. Global Injectable Thyroid Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Injectable Thyroid Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Injectable Thyroid Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Injectable Thyroid Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Injectable Thyroid Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Injectable Thyroid Drug Sales by Country (K Units), 2021–2026
Table 27. North America Injectable Thyroid Drug Sales by Country (K Units), 2027–2032
Table 28. North America Injectable Thyroid Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Injectable Thyroid Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Injectable Thyroid Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Injectable Thyroid Drug Sales by Country (K Units), 2021–2026
Table 32. Europe Injectable Thyroid Drug Sales by Country (K Units), 2027–2032
Table 33. Europe Injectable Thyroid Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Injectable Thyroid Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Injectable Thyroid Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Injectable Thyroid Drug Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Injectable Thyroid Drug Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Injectable Thyroid Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Injectable Thyroid Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Injectable Thyroid Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Injectable Thyroid Drug Sales by Country (K Units), 2021–2026
Table 42. Latin America Injectable Thyroid Drug Sales by Country (K Units), 2027–2032
Table 43. Latin America Injectable Thyroid Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Injectable Thyroid Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Injectable Thyroid Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Injectable Thyroid Drug Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Injectable Thyroid Drug Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Injectable Thyroid Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Injectable Thyroid Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Injectable Thyroid Drug Sales (K Units) by Type (2021–2026)
Table 51. Global Injectable Thyroid Drug Sales (K Units) by Type (2027–2032)
Table 52. Global Injectable Thyroid Drug Sales Market Share by Type (2021–2026)
Table 53. Global Injectable Thyroid Drug Sales Market Share by Type (2027–2032)
Table 54. Global Injectable Thyroid Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Injectable Thyroid Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Injectable Thyroid Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Injectable Thyroid Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Injectable Thyroid Drug Price (US$/Unit) by Type (2021–2026)
Table 59. Global Injectable Thyroid Drug Price (US$/Unit) by Type (2027–2032)
Table 60. Global Injectable Thyroid Drug Sales (K Units) by Application (2021–2026)
Table 61. Global Injectable Thyroid Drug Sales (K Units) by Application (2027–2032)
Table 62. Global Injectable Thyroid Drug Sales Market Share by Application (2021–2026)
Table 63. Global Injectable Thyroid Drug Sales Market Share by Application (2027–2032)
Table 64. Global Injectable Thyroid Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Injectable Thyroid Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Injectable Thyroid Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Injectable Thyroid Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Injectable Thyroid Drug Price (US$/Unit) by Application (2021–2026)
Table 69. Global Injectable Thyroid Drug Price (US$/Unit) by Application (2027–2032)
Table 70. Genzyme Corporation (Sanofi) Company Information
Table 71. Genzyme Corporation (Sanofi) Description and Business Overview
Table 72. Genzyme Corporation (Sanofi) Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Genzyme Corporation (Sanofi) Injectable Thyroid Drug Product
Table 74. Genzyme Corporation (Sanofi) Recent Developments/Updates
Table 75. Fresenius Kabi Company Information
Table 76. Fresenius Kabi Description and Business Overview
Table 77. Fresenius Kabi Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Fresenius Kabi Injectable Thyroid Drug Product
Table 79. Fresenius Kabi Recent Developments/Updates
Table 80. XGEN PHARMACEUTICALS DJB, Inc. Company Information
Table 81. XGEN PHARMACEUTICALS DJB, Inc. Description and Business Overview
Table 82. XGEN PHARMACEUTICALS DJB, Inc. Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. XGEN PHARMACEUTICALS DJB, Inc. Injectable Thyroid Drug Product
Table 84. XGEN PHARMACEUTICALS DJB, Inc. Recent Developments/Updates
Table 85. Zydus Lifesciences Company Information
Table 86. Zydus Lifesciences Description and Business Overview
Table 87. Zydus Lifesciences Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Zydus Lifesciences Injectable Thyroid Drug Product
Table 89. Zydus Lifesciences Recent Developments/Updates
Table 90. DMS Pharma Company Information
Table 91. DMS Pharma Description and Business Overview
Table 92. DMS Pharma Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. DMS Pharma Injectable Thyroid Drug Product
Table 94. DMS Pharma Recent Developments/Updates
Table 95. MAlA Pharmaceuticals, Inc. Company Information
Table 96. MAlA Pharmaceuticals, Inc. Description and Business Overview
Table 97. MAlA Pharmaceuticals, Inc. Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. MAlA Pharmaceuticals, Inc. Injectable Thyroid Drug Product
Table 99. MAlA Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. App Pharmaceuticals Company Information
Table 101. App Pharmaceuticals Description and Business Overview
Table 102. App Pharmaceuticals Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. App Pharmaceuticals Injectable Thyroid Drug Product
Table 104. App Pharmaceuticals Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Injectable Thyroid Drug Distributors List
Table 108. Injectable Thyroid Drug Customers List
Table 109. Injectable Thyroid Drug Market Trends
Table 110. Injectable Thyroid Drug Market Drivers
Table 111. Injectable Thyroid Drug Market Challenges
Table 112. Injectable Thyroid Drug Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injectable Thyroid Drug
Figure 2. Global Injectable Thyroid Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Injectable Thyroid Drug Market Share by Type: 2025 & 2032
Figure 4. Levothyroxine Sodium Product Picture
Figure 5. Liothyronine Sodium Product Picture
Figure 6. Global Injectable Thyroid Drug Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Injectable Thyroid Drug Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Online Sales
Figure 11. Other
Figure 12. Global Injectable Thyroid Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Injectable Thyroid Drug Market Size (US$ Million), 2021–2032
Figure 14. Global Injectable Thyroid Drug Sales (K Units), 2021–2032
Figure 15. Global Injectable Thyroid Drug Average Price (US$/Unit), 2021–2032
Figure 16. Injectable Thyroid Drug Report Years Considered
Figure 17. Injectable Thyroid Drug Sales Share by Manufacturers in 2025
Figure 18. Global Injectable Thyroid Drug Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Injectable Thyroid Drug Players: Market Share by Revenue in Injectable Thyroid Drug in 2025
Figure 20. Injectable Thyroid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Injectable Thyroid Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Injectable Thyroid Drug Sales Market Share by Country (2021–2032)
Figure 23. North America Injectable Thyroid Drug Revenue Market Share by Country (2021–2032)
Figure 24. United States Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Injectable Thyroid Drug Sales Market Share by Country (2021–2032)
Figure 27. Europe Injectable Thyroid Drug Revenue Market Share by Country (2021–2032)
Figure 28. Germany Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Injectable Thyroid Drug Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Injectable Thyroid Drug Revenue Market Share by Region (2021–2032)
Figure 35. China Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Injectable Thyroid Drug Sales Market Share by Country (2021–2032)
Figure 43. Latin America Injectable Thyroid Drug Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Injectable Thyroid Drug Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Injectable Thyroid Drug Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Injectable Thyroid Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Injectable Thyroid Drug by Type (2021–2032)
Figure 54. Global Revenue Market Share of Injectable Thyroid Drug by Type (2021–2032)
Figure 55. Global Injectable Thyroid Drug Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Injectable Thyroid Drug by Application (2021–2032)
Figure 57. Global Revenue Market Share of Injectable Thyroid Drug by Application (2021–2032)
Figure 58. Global Injectable Thyroid Drug Price (US$/Unit) by Application (2021–2032)
Figure 59. Injectable Thyroid Drug Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
